How Venezuelan Companies Can Source Pharma Products & CDMO Services from India

India is one of the largest pharmaceutical hubs in the world. It manufactures a wide range of drugs in large quantities for numerous countries. These drugs are comparatively inexpensive yet of high quality. Most Indian manufacturers adhere to international regulations and hold approvals from the US FDA, WHO GMP, and EU GMP. For this reason, India is considered a secure and reliable destination for purchasing medicines and health products. (Read: Why global pharma companies choose India for CDMO)

The healthcare and pharmaceutical industries in Venezuela are currently growing due to the increasing demand for low-cost drugs, chronic treatment medications, and biosimilars. There are several advantages to sourcing products from India to Venezuela. India can provide generic medicines, APIs, vaccines, injectables, herbal products, and medical devices. Contract Development and Manufacturing Organization (CDMO) services are also available. A CDMO helps businesses with product development, testing, and manufacturing, which is particularly useful when a company lacks its own manufacturing facility. This saves both time and money, simplifying the process.

This guide details the process of sourcing products and CDMO support from India to Venezuela. The language is kept simple to ensure that all readers can easily follow the process.

Why India Is a Leading Choice for Sourcing Pharma Products & CDMO Services

India is an excellent ally to numerous countries & It can also be a strong partenr for Venezuela.

• Large Production Base: The Indian medicine industry is very large. It manufactures tablets, capsules, syrups, creams, and injections. It produces not only complicated medicines but simple medicines as well. India possesses qualified personnel, effective laboratory and powerful systems. Due to this fact, India is able to make orders of small and big amount without difficulties.
   
• High Quality, Low Cost: Indian medicines are known for being high-quality and affordable. The cost of raw materials in India is lower, and labor is also cost-effective. Additionally, factories manufacture products in very large batches, further reducing costs. Strong competition among companies keeps prices fair. These lower drug prices can help Venezuela provide better healthcare to its population.
   
• Strong CDMO Support: India has many CDMO firms that assist in designing, testing and manufacturing of drugs. They can prepare both pilot and commercial-scale batches, conduct stability studies, and develop packaging designs. They can also help create the documentation required for regulatory approval. A Venezuelan company can retain its own brand while having an Indian CDMO manufacture the product—accelerating business growth.

Top Pharma Products Venezuela Can Import from India

• Generic Medicines: India produces a wide variety of generic drugs, including medicines for diabetes, blood pressure, infections, gastric issues, pain management, and asthma. These drugs are available in the form of tablets, capsules, syrups, injectables, and ointments.
   
• Active Pharmaceutical Ingredients (APIs): APIs are the core chemical components used to manufacture medicines, and India is one of the world’s leading API producers. Common examples include paracetamol, metformin, amoxicillin, azithromycin, losartan, and atorvastatin. These APIs can help Venezuela manufacture its own medicines and strengthen its domestic pharmaceutical industry.
   
• Specialty Medicines: India also manufactures high-value medicines such as cancer treatments, biosimilars, hormones, ophthalmic (eye-care) drugs, and vaccines. These products are expensive in many countries but are more affordable when sourced from India.
   
• Ayurvedic and Herbal Products: India is the birthplace of Ayurveda and produces a wide range of herbal oils, powders, tonics, and immunity-boosting products. These goods are widely exported as natural health and wellness products.
   
• Medical Devices: India has been exporting syringes, test kits, surgical equipment, and other equipment. These products support regular need of hospitals and clinics.

Step by Step Guide to start sourcing for Venezuelan Companies

This guide is designed to help businesses in Venezuela effectively begin sourcing products from India.

Step 1: Find Reliable Suppliers

• Look for suppliers that are WHO-GMP certified. Check if they also have certifications from regulatory bodies like the US FDA, EMA, MHRA, or TGA. These certifications ensure high-quality standards. India has several major pharmaceutical hubs, including Hyderabad, Ahmedabad, Mumbai, Pune, Baddi, and Chennai.

Step 2: Ask for Key Documents

• Ask for product catalogs, Certificates of Analysis (COAs), Certificates of Pharmaceutical Products (COPPs), stability data, price lists, and Minimum Order Quantities (MOQs). These documents will help you compare suppliers and ensure compliance with import regulations.

Step 3: Start With Sample Orders

• Request samples of the products you intend to purchase. Test them in a lab for quality, packaging, labeling, and expiry dates. If the samples pass the tests, you can proceed with larger orders.

Step 4: Study the import regulations of Venezuela

• Some products may require registration, safety testing, Spanish-language labels, or an import license. Certain products may also require cold-chain transportation. Many Indian exporters are already familiar with Latin American regulations and can help guide you through these requirements.

Step 5: Subcontract with a Powerful Logistics Partner

• Safe delivery relies on efficient logistics. Ensure that the logistics partner offers temperature-controlled shipping, expedited delivery, and secure packaging. India has major export centers in Mumbai, Delhi, Hyderabad, and Bengaluru that can facilitate smooth shipping to Venezuela.

Step 6: Make Long-Term Deals

• Long-term agreements help build trust and provide benefits like fixed prices, reliable supply, and better planning. Set clear terms regarding price, delivery times, volume, and quality to ensure a smooth and consistent relationship with your supplier.

The papers that are required are as follows:

- Certificate of Pharmaceutical Product (COPP)

- GMP Certificate 

- COA and Batch Records 

- Registration Dossier or CTD 

- Free Sale Certificate 

- Bill of Lading 

- Packing List 

- MSDS

The time taken by shipment is subject to mode.

Sea Freight - Time: 3 to 6 weeks. 

Applied to items of bulk and low risk.

Air Freight - Time: 4 to 10 days. 

Applied to high-value and urgent goods.

Cold Chain - Required insulin, needed vaccines or sensitive objects.

Main Indian Ports 

- Mumbai Port 
- Mundra Port 
- Chennai Port 

Delays can be avoided by good planning.

The main points to consider regarding Venezuela's pharmaceutical regulations are as follows:

• The import license is reviewed by the Ministry of Health.
• You must provide the drug dossier and quality data.
• Dossier reviews can be time-consuming.
• Stability should correspond to the local climate zone.
• Labeling must comply with local regulations.

It is also possible to read about how Indian CDMOs meet global standards.

India has mechanisms that are powerful to resolve such problems.

Venezuela can trust India as a cheap, quality, and reliable partner. India has had good suppliers, experienced staff, and extensive product selection that can be used to address the healthcare requirements of Venezuela. The long-term relationships assist both parties to develop and improve a future.

References

1. Pharmaceuticals Export Promotion Council of India (Pharmexcil) — official site: https://pharmexcil.com/
2. India Brand Equity Foundation (IBEF) — Pharmaceuticals infographic (May 2025): https://www.ibef.org/uploads/industry/Infrographics/large/Pharmaceuticals-Infographic-May-2025.pdf
3. U.S. Food and Drug Administration (FDA) — foreign inspected manufacturing sites list: https://www.fda.gov/media/98125/download
4. Central Drugs Standard Control Organization (CDSCO) — approved manufacturing sites by state (India): https://cdscoonline.gov.in/CDSCO/manuf_site
5. “India continues to top FDA-registered generics facilities” — article via PharmaCompass: https://www.pharmacompass.com/radio-compass-blog/india-continues-to-top-fda-registered-generics-facilities-sets-up-20-new-units-for-fy24
6. “Indian pharma exports strong at $4.9 billion in April-May” — press statement: https://ddnews.gov.in/en/indian-pharma-exports-strong-at-4-9-billion-april-may-says-pharmexcil/